To elucidate the mechanism of action specific to ER+ breast cancer cells, we investigated the expression levels of ER-α protein following treatment of MCF7 and MDA-MB-231 cells with SP-1-303 over a time course of 0.5h to 6h (Fig 4). Here, ESR1 is linked to breast carcinoma.